Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression S Terlecki-Zaniewicz, T Humer, T Eder, J Schmoellerl, E Heyes, ... Nature structural & molecular biology 28 (2), 190-201, 2021 | 76 | 2021 |
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia J Schmoellerl, IAM Barbosa, T Eder, T Brandstoetter, L Schmidt, B Maurer, ... Blood, The Journal of the American Society of Hematology 136 (4), 387-400, 2020 | 66 | 2020 |
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity A Skucha, J Ebner, J Schmöllerl, M Roth, T Eder, A César-Razquin, ... Nature Communications 9 (1), 1983, 2018 | 59 | 2018 |
Global map of oxytocin/vasopressin-like neuropeptide signalling in insects Z Liutkeviciute, J Koehbach, T Eder, E Gil-Mansilla, CW Gruber Scientific reports 6 (1), 39177, 2016 | 47 | 2016 |
Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide MG Di Giglio, M Muttenthaler, K Harpsøe, Z Liutkeviciute, P Keov, T Eder, ... Scientific Reports 7 (1), 41002, 2017 | 42 | 2017 |
The intraperitoneal transcriptome of the opportunistic pathogen Enterococcus faecalis in mice C Muller, M Cacaci, N Sauvageot, M Sanguinetti, T Rattei, T Eder, ... PLoS One 10 (5), e0126143, 2015 | 41 | 2015 |
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex L Schmidt, E Heyes, L Scheiblecker, T Eder, G Volpe, J Frampton, ... Leukemia 33 (7), 1608-1619, 2019 | 28 | 2019 |
STAT3β is a tumor suppressor in acute myeloid leukemia P Aigner, T Mizutani, J Horvath, T Eder, S Heber, K Lind, V Just, HP Moll, ... Blood Advances 3 (13), 1989-2002, 2019 | 25 | 2019 |
Oxytocin-like signaling in ants influences metabolic gene expression and locomotor activity Z Liutkevičiūtė, E Gil-Mansilla, T Eder, B Casillas-Pérez, MG Di Giglio, ... FASEB journal: official publication of the Federation of American Societies …, 2018 | 24 | 2018 |
EVI1 drives leukemogenesis through aberrant ERG activation J Schmoellerl, IAM Barbosa, M Minnich, F Andersch, L Smeenk, ... Blood 141 (5), 453-466, 2023 | 20 | 2023 |
Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML E Heyes, L Schmidt, G Manhart, T Eder, L Proietti, F Grebien Leukemia 35 (9), 2526-2538, 2021 | 16 | 2021 |
Comprehensive assessment of differential ChIP-seq tools guides optimal algorithm selection T Eder, F Grebien Genome Biology 23 (1), 119, 2022 | 14 | 2022 |
Regulation of the mitochondrion-fatty acid axis for the metabolic reprogramming of Chlamydia trachomatis during treatment with β-lactam antimicrobials K Shima, I Kaufhold, T Eder, N Käding, N Schmidt, IM Ogunsulire, ... MBio 12 (2), 10.1128/mbio. 00023-21, 2021 | 11 | 2021 |
Genome sequencing of Chlamydia trachomatis serovars E and F reveals substantial genetic variation T Eder, S Kobus, S Stallmann, S Stepanow, K Köhrer, JH Hegemann, ... Pathogens and disease 75 (9), ftx120, 2017 | 9 | 2017 |
Identification of CD4+ T cells with T follicular helper cell characteristics in the pig A Hoog, S Villanueva-Hernández, MA Razavi, K van Dongen, T Eder, ... Developmental & Comparative Immunology 134, 104462, 2022 | 8 | 2022 |
Allele discovery of ten candidate drought-response genes in Austrian oak using a systematically informatics approach based on 454 amplicon sequencing A Homolka, T Eder, D Kopecky, M Berenyi, K Burg, S Fluch BMC research notes 5, 1-9, 2012 | 8 | 2012 |
Antiviral immune response reveals host-specific virus infections in natural ant populations L Viljakainen, MA Fürst, AV Grasse, J Jurvansuu, J Oh, L Tolonen, T Eder, ... Frontiers in Microbiology 14, 1119002, 2023 | 7 | 2023 |
NVT: a fast and simple tool for the assessment of RNA-seq normalization strategies T Eder, F Grebien, T Rattei Bioinformatics 32 (23), 3682-3684, 2016 | 7 | 2016 |
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression E Heyes, AS Wilhelmson, A Wenzel, G Manhart, T Eder, MB Schuster, ... Nature Communications 14 (1), 6185, 2023 | 3 | 2023 |
SBNO2 is a critical mediator of STAT3-driven hematological malignancies T Brandstoetter, J Schmoellerl, R Grausenburger, S Kollmann, E Doma, ... Blood 141 (15), 1831-1845, 2023 | 2 | 2023 |